Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Heitjan

Showing results (31-40 of 123) with videos related to

Pageof 13
Sort By:
Clinical Trials (London, England)|July 12, 2020
Editorial: Clinical trial design in the era of COVID-19Colin B Begg, Mithat Gonen, Daniel F Heitjan
Biometrics|March 16, 2011
Prediction of individual long-term outcomes in smoking cessation trials using frailty modelsYimei Li, E Paul Wileyto, Daniel F Heitjan
Addiction (Abingdon, England)|June 3, 2011
Statistical analysis of daily smoking status in smoking cessation clinical trialsYimei Li, E Paul Wileyto, Daniel F Heitjan
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 8, 2009
A method comparison study of timeline followback and ecological momentary assessment of daily cigarette consumptionSandra D Griffith, Saul Shiffman, Daniel F Heitjan
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 16, 2012
Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapyRichard J Santen, Wei Yue, Daniel F Heitjan
Hormones & Cancer|May 2, 2013
Occult breast tumor reservoir: biological properties and clinical significanceRichard J Santen, Wei Yue, Daniel F Heitjan
Contemporary Clinical Trials Communications|February 27, 2020
Flexible, rule-based dose escalation: The cohort-sequence designShuang Li, Xian-Jin Xie, Daniel F Heitjan
Contemporary Clinical Trials|July 19, 2015
Real-time prediction of clinical trial enrollment and event counts: A reviewDaniel F Heitjan, Zhiyun Ge, Gui-Shuang Ying
Statistics in Medicine|May 24, 2005
An index of local sensitivity to nonignorable drop-out in longitudinal modellingGuoguang Ma, Andrea B Troxel, Daniel F Heitjan
Clinical Trials (London, England)|November 11, 2005
Nonparametric prediction of event times in randomized clinical trialsGui-shuang Ying, Daniel F Heitjan, Tai-Tsang Chen
Pageof 13

Showing results (31-40 of 123) with videos related to

Sort By:
Pageof 13
Clinical Trials (London, England)|July 12, 2020
Editorial: Clinical trial design in the era of COVID-19Colin B Begg, Mithat Gonen, Daniel F Heitjan
Biometrics|March 16, 2011
Prediction of individual long-term outcomes in smoking cessation trials using frailty modelsYimei Li, E Paul Wileyto, Daniel F Heitjan
Addiction (Abingdon, England)|June 3, 2011
Statistical analysis of daily smoking status in smoking cessation clinical trialsYimei Li, E Paul Wileyto, Daniel F Heitjan
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 8, 2009
A method comparison study of timeline followback and ecological momentary assessment of daily cigarette consumptionSandra D Griffith, Saul Shiffman, Daniel F Heitjan
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 16, 2012
Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapyRichard J Santen, Wei Yue, Daniel F Heitjan
Hormones & Cancer|May 2, 2013
Occult breast tumor reservoir: biological properties and clinical significanceRichard J Santen, Wei Yue, Daniel F Heitjan
Contemporary Clinical Trials Communications|February 27, 2020
Flexible, rule-based dose escalation: The cohort-sequence designShuang Li, Xian-Jin Xie, Daniel F Heitjan
Contemporary Clinical Trials|July 19, 2015
Real-time prediction of clinical trial enrollment and event counts: A reviewDaniel F Heitjan, Zhiyun Ge, Gui-Shuang Ying
Statistics in Medicine|May 24, 2005
An index of local sensitivity to nonignorable drop-out in longitudinal modellingGuoguang Ma, Andrea B Troxel, Daniel F Heitjan
Clinical Trials (London, England)|November 11, 2005
Nonparametric prediction of event times in randomized clinical trialsGui-shuang Ying, Daniel F Heitjan, Tai-Tsang Chen
Pageof 13